Sustained delivery of rhBMP-2 by Means of Poly(Lactic-co-Glycolic Acid) microspheres: Cranial bone regeneration without heterotopic ossification or craniosynostosis

Plastic and Reconstructive Surgery

Volumn 134, Issue 1, 2014, Pages 51-59

  Wink, Jason D ^a   Gerety, Patrick A ^a   Sherif, Rami D ^a   Lim, Youngshin ^a   Clarke, Nadya A ^a   Rajapakse, Chamith S ^a   Nah, Hyun Duck ^a   Taylor, Jesse A ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; LACTIC ACID; MICROSPHERE; POLYGLYCOLIC ACID; POLYLACTIC ACID POLYGLYCOLIC ACID COPOLYMER; POLYLACTIC ACID-POLYGLYCOLIC ACID COPOLYMER; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; BONE REGENERATION; CRANIOFACIAL SYNOSTOSIS; DRUG DELIVERY SYSTEM; DRUG EFFECT; FEMALE; HETEROTOPIC OSSIFICATION; MALE; PHYSIOLOGY; RABBIT; SKULL;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; BONE REGENERATION; CRANIOSYNOSTOSES; DRUG DELIVERY SYSTEMS; FEMALE; LACTIC ACID; MALE; MICROSPHERES; OSSIFICATION, HETEROTOPIC; POLYGLYCOLIC ACID; RABBITS; RECOMBINANT PROTEINS; SKULL; TRANSFORMING GROWTH FACTOR BETA;

EID: 84895775086     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0000000000000287     Document Type: Conference Paper

References (35)

1. McKay B. Local sustained delivery of recombinant human bone morphogenetic protein-2 (rhBMP-2). Conf Proc IEEE Eng Med Biol Soc. 2009;2009:236-237.
2. BMP 2Genetics Institute/Medtronic-Sofamor Danek/Integra. Bone morphogenetic protein 2-Genetics Institute/Medtronic-Sofamor Danek/Integra, INFUSE Bone Graft, recombinant human bone morphogenetic protein 2-Genetics Institute/Medtronic-Sofamor Danek/Integra, RhBMP 2-Genetics Institute/Medtronic-Sofamor Danek/Integra. BioDrugs 2002;16:376-377.
3. McKay WF, Peckham SM, Badura JM. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int Orthop. 2007;31:729-734.
4. Garrett MP, Kakarla UK, Porter RW, Sonntag VK. Formation of painful seroma and edema after the use of recombinant human bone morphogenetic protein-2 in posterolateral lumbar spine fusions. Neurosurgery 2010;66:1044-1049; discussion 1049.
5. Jones AL, Bucholz RW, Bosse MJ, et al; BMP-2 Evaluation in Surgery for Tibial Trauma-Allgraft (BESTT-ALL) Study Group. Recombinant human BMP-2 and allograft compared with autogenous bone graft for reconstruction of diaphyseal tibial fractures with cortical defects: A randomized, controlled trial. J Bone Joint Surg Am. 2006;88:1431-1441.
6. Woo EJ. Adverse events after recombinant human BMP2 in nonspinal orthopaedic procedures. Clin Orthop Relat Res. 2012;471:1707-1711.
7. Shah RK, Moncayo VM, Smitson RD, Pierre-Jerome C, Terk MR. Recombinant human bone morphogenetic protein 2-induced heterotopic ossification of the retroperitoneum, psoas muscle, pelvis and abdominal wall following lumbar spinal fusion. Skeletal Radiol. 2010;39:501-504.
8. Anderson CL, Whitaker MC. Heterotopic ossification associated with recombinant human bone morphogenetic protein-2 (infuse) in posterolateral lumbar spine fusion: A case report. Spine (Phila Pa 1976) 2012;37:E502-E506.
9. Kinsella CR Jr, Bykowski MR, Lin AY, et al. BMP-2-mediated regeneration of large-scale cranial defects in the canine: An examination of different carriers. Plast Reconstr Surg. 2011;127:1865-1873.
10. Kaneko H, Arakawa T, Mano H, et al. Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 2000;27:479-486.
11. Woo EJ. Adverse events reported after the use of recombinant human bone morphogenetic protein 2. J Oral Maxillofac Surg. 2012;70:765-767.
12. Perri B, Cooper M, Lauryssen C, Anand N. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion: A case study. Spine J. 2007;7:235-239.
13. Por YC, Barceló CR, Salyer KE, et al. Bone generation in the reconstruction of a critical size calvarial defect in an experimental model. J Craniofac Surg. 2008;19:383-392.
14. Smith DM, Afifi AM, Cooper GM, Mooney MP, Marra KG, Losee JE. BMP-2-based repair of large-scale calvarial defects in an experimental model: Regenerative surgery in cranioplasty. J Craniofac Surg. 2008;19:1315-1322.
15. Furuta Y, Piston DW, Hogan BL. Bone morphogenetic proteins (BMPs) as regulators of dorsal forebrain development. Development 1997;124:2203-2212.
16. Kinsella CR Jr, Cray JJ, Durham EL, et al. Recombinant human bone morphogenetic protein-2-induced craniosynostosis and growth restriction in the immature skeleton. Plast Reconstr Surg. 2011;127:1173-1181.
17. Elsalanty ME, Por YC, Genecov DG, et al. Recombinant human BMP-2 enhances the effects of materials used for reconstruction of large cranial defects. J Oral Maxillofac Surg. 2008;66:277-285.
18. Peel SA, Hu ZM, Clokie CM. In search of the ideal bone morphogenetic protein delivery system: In vitro studies on demineralized bone matrix, purified, and recombinant bone morphogenetic protein. J Craniofac Surg. 2003;14:284-291.
19. Borselli C, Ungaro F, Oliviero O, et al. Bioactivation of collagen matrices through sustained VEGF release from PLGA microspheres. J Biomed Mater Res A 2010;92:94-102.
20. Rajapakse CS, Leonard MB, Bhagat YA, Sun W, Magland JF, Wehrli FW. Micro-MR imaging-based computational biomechanics demonstrates reduction in cortical and trabecular bone strength after renal transplantation. Radiology 2012;262:912-920.
21. Rajapakse CS, Magland JF, Wald MJ, et al. Computational biomechanics of the distal tibia from high-resolution MR and micro-CT images. Bone 2010;47:556-563.
22. Wehrli FW, Rajapakse CS, Magland JF, Snyder PJ. Mechanical implications of estrogen supplementation in early postmenopausal women. J Bone Miner Res. 2010;25:1406-1414.
23. Zhang XH, Liu XS, Vasilic B, et al. In vivo microMRI-based finite element and morphological analyses of tibial trabecular bone in eugonadal and hypogonadal men before and after testosterone treatment. J Bone Miner Res. 2008;23:1426-1434.
24. Zysset PK, Guo XE, Hoffler CE, Moore KE, Goldstein SA. Elastic modulus and hardness of cortical and trabecular bone lamellae measured by nanoindentation in the human femur. J Biomech. 1999;32:1005-1012.
25. Vayron R, Barthel E, Mathieu V, Soffer E, Anagnostou F, Haiat G. Nanoindentation measurements of biomechanical properties in mature and newly formed bone tissue surrounding an implant. J Biomech Eng. 2012;134:021007.
26. Zara JN, Siu RK, Zhang X, et al. High doses of bone morphogenetic protein 2 induce structurally abnormal bone and inflammation in vivo. Tissue Eng Part A 2011;17:1389-1399.
27. DeCesare GE, Cooper GM, Smith DM, et al. Novel animal model of calvarial defect in an infected unfavorable wound: Reconstruction with rhBMP-2. Plast Reconstr Surg. 2011;127:588-594.
28. Kinsella CR Jr, Cray JJ, Smith DM, et al. Novel model of calvarial defect in an infected unfavorable wound: Reconstruction with rhBMP-2. Part II. J Craniofac Surg. 2012;23:410-414.
29. Kinsella CR Jr, Macisaac ZM, Cray JJ, et al. Novel animal model of calvarial defect: Part III. Reconstruction of an irradiated wound with rhBMP-2. Plast Reconstr Surg. 2012;130:643e-650e.
30. Rapp SJ, Jones DC, Gerety P, Taylor JA. Repairing criticalsized rat calvarial defects with progenitor cell-seeded acellular periosteum: A novel biomimetic scaffold. Surgery 2012;152:595-604, 605.e1; discussion 604.
31. Wikesjö UM, Qahash M, Polimeni G, et al. Alveolar ridge augmentation using implants coated with recombinant human bone morphogenetic protein-2: Histologic observations. J Clin Periodontol. 2008;35:1001-1010.
32. Kawai M, Bessho K, Maruyama H, Miyazaki J, Yamamoto T. Human BMP-2 gene transfer using transcutaneous in vivo electroporation induced both intramembranous and endochondral ossification. Anat Rec A Discov Mol Cell Evol Biol. 2005;287:1264-1271.
33. Kuboki Y, Saito T, Murata M, et al. Two distinctive BMP-carriers induce zonal chondrogenesis and membranous ossification, respectively; geometrical factors of matrices for cell-differentiation. Connect Tissue Res. 1995;32:219-226.
34. Wang L, Huang Y, Pan K, Jiang X, Liu C. Osteogenic responses to different concentrations/ratios of BMP-2 and bFGF in bone formation. Ann Biomed Eng. 2010;38:77-87.
35. Akino K, Mineta T, Fukui M, Fujii T, Akita S. Bone morphogenetic protein-2 regulates proliferation of human mesenchymal stem cells. Wound Repair Regen. 2003;11:354-360.